Last updated on April 2019

Extension Study for the Port Delivery System With Ranibizumab (Portal)


Brief description of study

This study will evaluate the long-term safety and tolerability of the Port Delivery System (PDS) with ranibizumab 100 mg/mL with refills administered every 24 weeks (Q24W) for approximately 144 weeks in participants with neovascular age-related macular degeneration (nAMD) who have completed either Phase II Study GX28228 or Phase III Study GR40548.

Clinical Study Identifier: NCT03683251

Contact Investigators or Research Sites near you

Start Over

The Retina Partners

Encino, CA United States
  Connect »

Jules Stein Eye Institute/ UCLA

Los Angeles, CA United States
  Connect »

N CA Retina Vitreous Assoc

Mountain View, CA United States
  Connect »

Retinal Consultants Med Group

Sacramento, CA United States
  Connect »

West Coast Retina Medical Group

San Francisco, CA United States
  Connect »

UCSF; Ophthalmology

San Francisco, CA United States
  Connect »

Orange County Retina Med Group

Santa Ana, CA United States
  Connect »

California Retina Consultants

Santa Barbara, CA United States
  Connect »

Florida Eye Microsurgical Inst

Boynton Beach, FL United States
  Connect »

Retina Specialty Institute

Pensacola, FL United States
  Connect »

Retina Vitreous Assoc of FL

Saint Petersburg, FL United States
  Connect »

Southeast Retina Center

Augusta, GA United States
  Connect »

Wolfe Eye Clinic

West Des Moines, IA United States
  Connect »

Retina Associates of Kentucky

Lexington, KY United States
  Connect »

Paducah Retinal Center

Paducah, KY United States
  Connect »

Retina Group of Washington

Chevy Chase, MD United States
  Connect »

Retina Specialists

Towson, MD United States
  Connect »

Foundation for Vision Research

Grand Rapids, MI United States
  Connect »

Vitreoretinal Surgery

Edina, MN United States
  Connect »

Sierra Eye Associates

Reno, NV United States
  Connect »

Retina Center of New Jersey

Bloomfield, NJ United States
  Connect »

Retina Assoc of Western NY

Rochester, NY United States
  Connect »

Char Eye Ear &Throat Assoc

Charlotte, NC United States
  Connect »

Cincinnati Eye Institute

Cincinnati, OH United States
  Connect »

Retina Northwest

Portland, OR United States
  Connect »

Palmetto Retina Center

Florence, SC United States
  Connect »

Charles Retina Institution

Germantown, TN United States
  Connect »

Tennessee Retina PC

Nashville, TN United States
  Connect »

Texas Retina Associates

Arlington, TX United States
  Connect »

Retina Research Center

Austin, TX United States
  Connect »

Med Center Ophthalmology Assoc

San Antonio, TX United States
  Connect »

Retina Associates of Utah

Salt Lake City, UT United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.